Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia.

Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL.

Mol Psychiatry. 2007 Jan;12(1):105-13, 1. Epub 2006 Oct 10.

PMID:
17033628
2.

Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study.

Prasad KM, Eack SM, Goradia D, Pancholi KM, Keshavan MS, Yolken RH, Nimgaonkar VL.

Am J Psychiatry. 2011 Aug;168(8):822-30. doi: 10.1176/appi.ajp.2011.10101423. Epub 2011 Jun 1.

3.

Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis.

Whitford TJ, Wood SJ, Yung A, Cocchi L, Berger G, Shenton ME, Kubicki M, Phillips L, Velakoulis D, Yolken RH, Pantelis C, McGorry P, Amminger GP.

Schizophr Res. 2012 Mar;135(1-3):175-80. doi: 10.1016/j.schres.2011.11.003. Epub 2012 Jan 12.

4.

Grey matter changes associated with host genetic variation and exposure to Herpes Simplex Virus 1 (HSV1) in first episode schizophrenia.

Prasad KM, Bamne MN, Shirts BH, Goradia D, Mannali V, Pancholi KM, Xue B, McClain L, Yolken RH, Keshavan MS, Nimgaonkar VL.

Schizophr Res. 2010 May;118(1-3):232-9. doi: 10.1016/j.schres.2010.01.007. Epub 2010 Feb 6.

5.

Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1137-48. doi: 10.1093/schbul/sbs046. Epub 2012 Apr 6. Review.

6.

Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.

Lui S, Deng W, Huang X, Jiang L, Ma X, Chen H, Zhang T, Li X, Li D, Zou L, Tang H, Zhou XJ, Mechelli A, Collier DA, Sweeney JA, Li T, Gong Q.

Am J Psychiatry. 2009 Feb;166(2):196-205. doi: 10.1176/appi.ajp.2008.08020183. Epub 2008 Nov 3. Erratum in: Am J Psychiatry. 2009 Feb;166(2):237.

PMID:
18981063
7.

Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.

Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL.

Schizophr Res. 2008 Dec;106(2-3):268-74. doi: 10.1016/j.schres.2008.07.017. Epub 2008 Sep 17.

8.

Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.

Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R.

Schizophr Res. 2012 Jan;134(1):83-8. doi: 10.1016/j.schres.2011.10.003. Epub 2011 Nov 1.

PMID:
22048011
9.

Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk.

Starr JR, Daling JR, Fitzgibbons ED, Madeleine MM, Ashley R, Galloway DA, Schwartz SM.

Cancer Res. 2001 Dec 1;61(23):8459-64. Erratum in: Cancer Res 2002 Apr 15;62(8):2445.

10.

Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia.

Schretlen DJ, Vannorsdall TD, Winicki JM, Mushtaq Y, Hikida T, Sawa A, Yolken RH, Dickerson FB, Cascella NG.

Schizophr Res. 2010 May;118(1-3):224-31. doi: 10.1016/j.schres.2010.01.008. Epub 2010 Feb 13.

PMID:
20153952
11.

Seropositivity of neurotropic infectious agents in first-episode schizophrenia patients and the relationship with positive and negative symptoms.

Bolu A, Oznur T, Tok D, Balikci A, Sener K, Celik C, Gulsun M.

Psychiatr Danub. 2016 Jun;28(2):132-8.

12.

Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.

Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A.

Ethiop Med J. 2011 Jul;49(3):211-20.

PMID:
21991754
13.

Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients.

Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF.

J Med Virol. 2005 Feb;75(2):300-6.

PMID:
15602731
14.

Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.

Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS.

Arch Gen Psychiatry. 2002 Nov;59(11):1002-10.

PMID:
12418933
15.

Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.

Witthaus H, Kaufmann C, Bohner G, Ozgürdal S, Gudlowski Y, Gallinat J, Ruhrmann S, Brüne M, Heinz A, Klingebiel R, Juckel G.

Psychiatry Res. 2009 Sep 30;173(3):163-9. doi: 10.1016/j.pscychresns.2008.08.002. Epub 2009 Jul 17.

PMID:
19616415
16.

Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia.

Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):587-91. Epub 2005 Apr 13.

PMID:
15866362
17.

Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders.

Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP, Buonomo AR, Portella G, Vallefuoco L, Settimi A, Pascotto A, Borgia G, Bravaccio C.

In Vivo. 2014 Jul-Aug;28(4):667-71.

PMID:
24982239
18.

Phospholipase A2 activity is associated with structural brain changes in schizophrenia.

Smesny S, Milleit B, Nenadic I, Preul C, Kinder D, Lasch J, Willhardt I, Sauer H, Gaser C.

Neuroimage. 2010 Oct 1;52(4):1314-27. doi: 10.1016/j.neuroimage.2010.05.009. Epub 2010 May 18.

PMID:
20478385
19.

A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.

Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JH, Minzenberg MJ, Ragland JD, Solomon M, Carter CS.

JAMA Psychiatry. 2015 Mar;72(3):226-34. doi: 10.1001/jamapsychiatry.2014.2178.

20.

Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.

Nenadic I, Dietzek M, Schönfeld N, Lorenz C, Gussew A, Reichenbach JR, Sauer H, Gaser C, Smesny S.

Schizophr Res. 2015 Feb;161(2-3):169-76. doi: 10.1016/j.schres.2014.10.041. Epub 2014 Dec 12.

PMID:
25497442

Supplemental Content

Support Center